Clinical Trials Sponsored by Medlogics Device Corporation

Total 65 results

Medlogics Device Corporation
Stanford University; Baim Institute for Clinical Research

Unknown

Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease

Coronary Artery Disease

Israel, United Kingdom, Netherlands, Germany
Abbott Medical Devices
Thoratec Corporation

Terminated

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Cardiogenic Shock

Hungary, Germany, Czechia, Netherlands
Abbott Medical Devices
Thoratec Corporation

Completed

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy

Cardiomyopathies | Ventricular Dysfunction | Heart Failure, Congestive

United States, Canada
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Cardiomyopathies | Ventricular Dysfunction | Heart Failure, Congestive

United States, Canada
Abbott Medical Devices
Thoratec Corporation

Completed

MOMENTUM 3 IDE Clinical Study Protocol (HM3™)

Advanced Refractory Left Ventricular Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

PREVENtion of HeartMate II Pump Thrombosis (PREVENT)

HeartMate II Pump Thrombosis

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Driveline Silicone Skin Interface Registry (SSI)

Driveline Heart-assisted Device Related Infection

United States
Abbott Medical Devices
Thoratec Corporation

Completed

CentriMag RVAS U.S. Post-approval Study Protocol (CMagRVAS)

Right Ventricular Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management (ROADMAP)

Heart Failure

United States
Abbott Medical Devices
Thoratec Corporation

Completed

HeartMate 3™ LIS Study (HM 3 LIS)

Heart Failure | Cardiovascular Disease

Germany, Czechia
Abbott Medical Devices
Thoratec Corporation

Completed

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study (RESIST)

Left Ventricular Assist Device | Percutaneous Lead Management

United States
Abbott Medical Devices
Thoratec Corporation

Withdrawn

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients

Heart Failure
Abbott Medical Devices
Guidant Corporation

Completed

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Atherosclerotic Disease, Carotid

United States
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Cruris

Tinea Cruris

United States, Puerto Rico, Honduras, El Salvador, Belize
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Pedis

Tinea Pedis

United States, Belize
Medicis Global Service Corporation

Completed

Study of Restylane and Perlane in the Correction of Peri-Oral Wrinkles

Peri-oral Wrinkles

United States
Medicis Global Service Corporation

Completed

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Seborrheic Dermatitis

United States
Medicis Global Service Corporation

Completed

Safety/Efficacy Study of Restylane® in Lip Augmentation

Lip Augmentation

United States
Medicis Global Service Corporation

Completed

Topical Antifungal Treatment for Tinea Pedis

Tinea Pedis

United States, Puerto Rico
Medicis Global Service Corporation

Unknown

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

Facial Volume

United States
Medicis Global Service Corporation

Completed

Combination Treatment for Moderate to Severe Acne

Acne

United States
Medicis Global Service Corporation

Completed

Safety and Efficacy Study to Treat Bacterial Vaginosis

Bacterial Vaginosis

United States
Medicis Global Service Corporation

Unknown

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Actinic Keratosis

United States
Shin Yukuhashi Hospital
Abbott Medical Devices; Cordis Corporation

Unknown

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion (J-REVERSE)

Ischemic Heart Disease

Japan
Abbott Medical Devices
Thoratec Corporation; Thoratec Europe Ltd

Completed

HeartMate 3 ELEVATE™ Registry (ELEVATE™)

Heart Failure | Cardiovascular Disease | Ventricular Dysfunction

Italy, United Kingdom, Denmark, Germany, Singapore, Czechia, Kazakhstan, Netherlands, Austria, Israel, Poland
Yale University
Boston Scientific Corporation; Medtronic; Abbott Medical Devices

Completed

Safety of Sports for Patients With Implantable Cardioverter-Defibrillators

Heart Arrhythmias

United States, Belgium, Canada, Switzerland, Israel, Netherlands, Germany, Australia, Czech Republic, France, Norway, Poland, Spain, United Kingdom
Aarhus University Hospital Skejby
Abbott Medical Devices; Cordis Corporation

Completed

Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial (CLOSE-UP II)

Coronary Disease

Denmark
University of Adelaide
Boston Scientific Corporation; Medtronic; Abbott Medical Devices

Completed

Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF) (CAAN-AF)

Heart Failure | Atrial Fibrillation

Australia, United Kingdom, New Zealand, Malaysia, Germany
Midwest Heart Foundation
Boston Scientific Corporation; Medtronic; Abbott Medical Devices

Completed

Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Implantable Cardioverter Defibrillators (MAGNET)

Heart Failure | Arrhythmia | Sudden Cardiac Death

United States
Medicis Global Service Corporation
Q-Med Scandinavia, Inc.

Completed

Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds

Nasolabial Folds

United States
Medicis Global Service Corporation
Q-Med Scandinavia, Inc.

Completed

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

Nasolabial Folds

United States
Chiron Corporation

Unknown

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

HIV Infections

United States
Chiron Corporation

Completed

A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients

HIV Infections

United States
Chiron Corporation

Completed

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

HIV Infections | HIV Seronegativity

United States
Celgene Corporation

Completed

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

HIV Infections | HIV Wasting Syndrome

United States
Chiron Corporation

Completed

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

HIV Infections

United States
Celgene Corporation

Completed

A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome

HIV Infections | HIV Wasting Syndrome

United States
Chiron Corporation

Completed

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
Abbott Medical Devices
Thoratec Corporation; KCRI; Center for Life Sciences; Emergo

Completed

HeartMate 3™ CE Mark Clinical Investigation Plan (HM3 CE Mark)

Advanced Refractory Left Ventricular Heart Failure

Germany, Australia, Austria, Canada, Czechia, Kazakhstan
Population Health Research Institute
Hamilton Health Sciences Corporation; Abbott Medical Devices

Terminated

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia (CEASE-VT)

Tachycardia, Ventricular | Defibrillators, Implantable

United States, Canada, China
Rigshospitalet, Denmark
Medtronic; Abbott Medical Devices; Biosense Webster, Inc.; Guidant Corporation

Completed

A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation

Atrial Fibrillation | Arrhythmia

Denmark
University Hospital, Caen
Boston Scientific Corporation; Abbott Medical Devices; Acist Medical Systems

Completed

Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries (FFR-DS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Stenosis

France
Scripps Health
Boston Scientific Corporation; Abbott Medical Devices; Biotronik, Inc.; Scripps...

Completed

The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) (MagnaSafe)

Need for MRI Imaging With Pacemaker or | Implantable Cardioverter Defibrillator Implanted

United States
The Immune Response Corporation

Completed

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

HIV Infections

United States
The Immune Response Corporation

Completed

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

HIV Infections

United States
The Immune Response Corporation

Completed

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

HIV Infections

United States
Edward Hospital
Boston Scientific Corporation; Medtronic; Abbott Medical Devices

Completed

ICD-ON Registry: Periop Management of Cardiac Devices

Surgery | ICD | Oversensing Cardiac Pacemaker

United States
University of Jena
Boston Scientific Corporation; Abbott Medical Devices; B. Braun Melsungen AG

Completed

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents (OCTOPUS)

Stents | Neointimal Proliferation

Germany
Tokai University
Abbott Medical Devices; Kaneka Medical America LLC; Terumo Medical Corporation; Asahi Intech and other collaborators

Completed

Guidewire for Chronic Total Occlusion (G-FORCE)

Coronary Occlusion

Japan

Clinical Trials Sponsored by Medlogics Device Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations